The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Cerebrovascular reserve capacity is impaired in patients with sickle cell disease
Abstract
Sickle cell disease (SCD) is associated with a high incidence of ischemic stroke. SCD is characterized by hemolytic anemia, resulting in reduced nitric oxide-bioavailability, and by impaired cerebrovascular hemodynamics. Cerebrovascular CO2 responsiveness is nitric oxide dependent and has been related to an increased stroke risk in microvascular diseases. We questioned whether cerebrovascular CO2 responsiveness is impaired in SCD and related to hemolytic anemia. Transcranial Doppler-determined mean cerebral blood flow velocity (Vmean), near-infrared spectroscopy-determined cerebral oxygenation, and end-tidal CO2 tension were monitored during normocapnia and hypercapnia in 23 patients and 16 control subjects. Cerebrovascular CO2 responsiveness was quantified as Δ% Vmean and Δμmol/L cerebral oxyhemoglobin, deoxyhemoglobin, and total hemoglobin per mm Hg change in end-tidal CO2 tension. Both ways of measurements revealed lower cerebrovascular CO2 responsiveness in SCD patients versus controls (Vmean, 3.7, 3.1-4.7 vs 5.9, 4.6-6.7 Δ% Vmean per mm Hg, P < .001; oxyhemoglobin, 0.36, 0.14-0.82 vs 0.78, 0.61-1.22 Δμmol/L per mm Hg, P = .025; deoxyhemoglobin, 0.35, 0.14-0.67 vs 0.58, 0.41-0.86 Δμmol/L per mm Hg, P = .033; total-hemoglobin, 0.13, 0.02-0.18 vs 0.23, 0.13-0.38 Δμmol/L per mm Hg, P = .038). Cerebrovascular CO2 responsiveness was not related to markers of hemolytic anemia. In SCD patients, impaired cerebrovascular CO2 responsiveness reflects reduced cerebrovascular reserve capacity, which may play a role in pathophysiology of stroke.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the cerebral autoregulatory capacity, i.e., the capacity to adjust vessel volume in response to carbon monoxide challenge or systemic blood pressure changes, is impaired in SCD (137, 138).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [138]
Citations
Cites
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Pathogenesis of Leukoaraiosis: A Review
Pantoni, L., & Garcia, J. H. (1997) · Stroke · doi:10.1161/01.str.28.3.652 · Cited by 1,225
Paulson, O. B., Strandgaard, S., & Edvinsson, L. (1990) · PubMed · Cited by 1,111
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Morris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 763
MRI Measures of Middle Cerebral Artery Diameter in Conscious Humans During Simulated Orthostasis
Serrador, J. M., Picot, P. A., Rutt, B. K., Shoemaker, J. K., & Bondar, R. L. (2000) · Stroke · doi:10.1161/01.str.31.7.1672 · Cited by 717
Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa050460 · Cited by 635
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Pulmonary hypertension and nitric oxide depletion in sickle cell disease
Bunn, H. F., Nathan, D. G., Dover, G. J., Hebbel, R. P., Platt, O. S., Rosse, W. F., & Ware, R. E. (2010) · Blood · doi:10.1182/blood-2010-02-268193 · Cited by 202
Chen, J. J., & Pike, G. B. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.07.003 · Cited by 131
Sickle cell disease: a review for the internist
Pinto, V. M., Balocco, M., Quintino, S., & Forni, G. L. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-019-02160-x · Cited by 114
Sickle cell disease: Clinical presentation and management of a global health challenge
Houwing, M. E., de Pagter, P. J., van Beers, E. J., Biemond, B. J., Rettenbacher, E., Rijneveld, A. W., Schols, E. M., Philipsen, J. N. J., Tamminga, R. Y. J., van Draat, K. F., et al. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.05.004 · Cited by 122
Self-citation
Metadata
- Authors
- Nur, E., Kim, Y.-S., Truijen, J., van Beers, E. J., Davis, S. C. A. T., Brandjes, D. P., Biemond, B. J., & van Lieshout, J. J.
- Affiliations
- Slotervaartziekenhuis (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Department of Internal Medicine, Slotervaart Hospital, Amsterdam;
- Department of Internal Medicine and
- Corresponding author
- Nur, Erfan
- Kim, Yu-Sok
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2009-10-15
- Volume
- 114
- Issue
- 16
- Pages
- 3473-3478
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2047574524
- Cited by
- 79
- References
- 47
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 4 · 2020: 4 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 13 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 6
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- sickle cell disease, cerebrovascular reserve, ischemic stroke, hemolytic anemia, nitric oxide bioavailability, cerebral blood flow velocity, cerebral oxygenation, hypercapnia, stroke risk
- MeSH terms
- Adult, Anemia, Sickle Cell, Blood Flow Velocity, Carbon Dioxide, Brain Ischemia, Cerebrovascular Circulation, Female, Hemoglobins, Humans, Male, Nitric Oxide, Oxygen, Oxyhemoglobins, Risk Factors, Incidence, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebrovascular reserve capacity is impaired in patients with sickle cell disease. https://app.cochat.ai/papers/10.1182/blood-2009-05-223859
- The paper
- Nur, E., Kim, Y.-S., Truijen, J., van Beers, E. J., Davis, S. C. A. T., Brandjes, D. P., Biemond, B. J., & van Lieshout, J. J. (2009). Cerebrovascular reserve capacity is impaired in patients with sickle cell disease. Blood. https://doi.org/10.1182/blood-2009-05-223859
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.